A

Artelo Biosciences, Inc.

17 employees

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Basic info

pharmaceutical manufacturing

Biotechnology

FABP5 inhibitors

CBD

Oncology

Pharmaceutical

Endocannabinoid Modulation

Life Science

synthetic cannabinoids

2017